arrow
I

Ivonne Jericó

servicio navarro de salud-osasunbidea
H指数:24
被引数:1,879

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Advancing Personalized Medicine in Alzheimer's Disease: Liquid Biopsy Epigenomics Unveil APOE ε4-Linked Methylation Signatures

推进阿尔茨海默病个性化医学:液体活检表观基因组学揭示APOE ε4相关甲基化特征

2025-04-051
OA
Neuropathological spectrum of anti-IgLON5 disease and stages of brainstem tau pathology: updated neuropathological research criteria of the disease-related tauopathy

anti-IgLON5疾病的神经病理谱和脑干tau病理分期: 疾病相关tau病的最新神经病理研究标准

2024-10-140
OAAI
Identification of a pathogenic mutation in ARPP21 in patients with amyotrophic lateral sclerosis

肌萎缩侧索硬化患者ARPP21致病突变的鉴定

2024-07-021
PRE
Cost analysis of treatment with therapeutic plasma exchange versus treatment with intravenous immunoglobulins in patients with immune-based neurological diseases. Proposal for optimizing the use of plasmatic blood products

治疗性血浆置换与静脉注射免疫球蛋白治疗免疫性神经系统疾病的成本分析。关于优化血浆血液制品使用的建议

2024-05-010
OAAI
Expanding the Clinical Spectrum of DRP2-Associated Charcot-Marie-Tooth Disease

扩大DRP2-Associated charcot-marie-tooth病的临床范围

2024-04-091
PRE
Association of Blood-Based DNA Methylation Markers With Late-Onset Alzheimer Disease

基于血液的DNA甲基化标记与迟发性阿尔茨海默病的关联

2023-12-058
OAAI
Drug-refractory myasthenia gravis: Clinical characteristics, treatments, and outcome
2022-01-2631
OA
Clinical and therapeutic features of myasthenia gravis in adults based on age at onset
2020-03-1791
OAAI
Reply to: Mitochondrial Parkinsonism due to SPG7/Paraplegin Variants with Secondary mtDNA Depletion
2019-12-170
PREAI
Parkinsonism and spastic paraplegia type 7: Expanding the spectrum of mitochondrial Parkinsonism

帕金森病和痉挛性截瘫7型: 扩大线粒体帕金森病的范围

2019-08-2142
PREAI
DNA methylation signature of human hippocampus in Alzheimer's disease is linked to neurogenesis

阿尔茨海默病中人类海马的DNA甲基化特征与神经发生有关

2019-06-1974
OAAI